WallStSmart
SGRY

Surgery Partners Inc

NASDAQ: SGRY · HEALTHCARE · MEDICAL CARE FACILITIES

$13.87
-3.34% today

Updated 2026-04-29

Market cap
$1.81B
P/E ratio
P/S ratio
0.55x
EPS (TTM)
$-0.61
Dividend yield
52W range
$11 – $24
Volume
1.5M

Surgery Partners Inc (SGRY) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-63.5%
Last 4 quarters
Revenue YoY growth
+2.4%
Most recent quarter
EPS YoY growth
-72.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-12.0%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-26.8%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-02$0.12-60.5%$15.50$13.92-10.2%
2025-11-10$0.13-38.1%$21.50$15.75-26.8%
2025-08-05$-0.02-112.5%$22.22$22.41+0.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.30$0.12-60.5%$885.00M+2.4%
2025-09-30$0.21$0.13-38.1%$821.50M+6.6%
2025-06-30$0.16$-0.02-112.5%$826.20M+8.4%
2025-03-31$0.07$0.04-42.9%$776.00M+8.2%
2024-12-31$0.38$0.44+16.7%$864.40M+17.5%
2024-09-30$0.25$-0.25-200.5%$770.40M+14.3%
2024-06-30$0.20$0.21+5.0%$762.10M+14.2%
2024-03-31$0.07$0.10+42.9%$717.40M
2023-12-31$0.38$0.44+15.8%$735.40M
2023-09-30$0.16$0.19+18.8%$674.10M
2023-06-30$0.08$0.28+250.0%$667.60M

Frequently asked questions

Has Surgery Partners Inc beaten earnings estimates?
Surgery Partners Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -63.5% over the last 4 quarters.
How does SGRY stock react to earnings?
SGRY stock has moved an average of -12.0% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Surgery Partners Inc's revenue growth rate?
Surgery Partners Inc reported year-over-year revenue growth of +2.4% in its most recent quarter, with EPS growing -72.7% year-over-year.